Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

Similar articles for PubMed (Select 9389397)

1.

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB.

Ann Surg. 1997 Nov;226(5):632-41. Review.

2.

Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.

Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ.

J Am Coll Surg. 2009 May;208(5):738-47; discussion 747-9. doi: 10.1016/j.jamcollsurg.2008.12.031.

PMID:
19476827
3.
4.

Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial.

Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, Yeo CJ.

J Gastrointest Surg. 2004 Nov;8(7):766-72; discussion 772-4.

PMID:
15531229
5.

Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.

Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, Choti MA, Coleman J, Hodgin MB, Sauter PK, Sonnenday CJ, Wolfgang CL, Marohn MR, Yeo CJ.

J Gastrointest Surg. 2006 Nov;10(9):1280-90; discussion 1290.

PMID:
17114014
6.

Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.

Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.

Am Surg. 2004 Mar;70(3):222-6; discussion 227.

PMID:
15055845
7.

Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.

Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK.

Eur J Surg Oncol. 2008 Aug;34(8):868-75. doi: 10.1016/j.ejso.2008.01.014. Epub 2008 Mar 4.

PMID:
18299182
8.

Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.

Poon RT, Lo SH, Fong D, Fan ST, Wong J.

Am J Surg. 2002 Jan;183(1):42-52.

PMID:
11869701
9.

The efficacy of the prophylactic use of octreotide after a pancreaticoduodenectomy.

Moon HJ, Heo JS, Choi SH, Joh JW, Choi DW, Kim YI.

Yonsei Med J. 2005 Dec 31;46(6):788-93.

10.

Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.

Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr.

J Am Coll Surg. 2007 Oct;205(4):546-57. Epub 2007 Aug 23.

PMID:
17903728
11.

Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.

Popiela T, Kedra B, Sierzega M, Gurda A.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1484-8.

PMID:
15362783
12.

Decreasing the pancreatic leak rate after pancreaticoduodenectomy.

Poon RT, Fan ST.

Adv Surg. 2008;42:33-48. Review.

PMID:
18953808
13.

Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Cullen JJ, Sarr MG, Ilstrup DM.

Am J Surg. 1994 Oct;168(4):295-8.

PMID:
7524375
14.

Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.

Fernández-Cruz L, Jiménez Chavarría E, Taurà P, Closa D, Boado MA, Ferrer J.

HPB (Oxford). 2013 May;15(5):392-9. doi: 10.1111/j.1477-2574.2012.00608.x. Epub 2012 Nov 19.

15.

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial.

Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, Fegiz G, Fissi S, Roviaro G, Peracchia A, et al.

Surgery. 1995 Jan;117(1):26-31.

PMID:
7809832
16.

An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF.

J Am Coll Surg. 2003 Jun;196(6):954-64. Review.

PMID:
12788434
17.

[Pancreatic anastomotic fistula after pancreaticoduodenectomy: incidence, significance and treatment].

Tocchi A, Lepre L, Mazzoni G, Costa G, Liotta G, Miccini M, Bettelli E, Cassini D.

G Chir. 2002 May;23(5):185-9. Italian.

PMID:
12228969
18.

[Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].

Briceño Delgado FJ, López Cillero P, Rufián Peña S, Solórzano Peck G, Miño Fugarolas G, Pera Madrazo C.

Rev Esp Enferm Dig. 1998 Oct;90(10):687-94. Spanish.

PMID:
9824933
19.

Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy.

Hesse UJ, De Decker C, Houtmeyers P, Demetter P, Ceelen W, Pattyn P, Troisi R, de Hemptinne B.

Acta Chir Belg. 2005 Aug;105(4):383-7.

PMID:
16184721
20.

The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.

Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.

Clin Transplant. 2005 Jun;19(3):299-303.

PMID:
15877788
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk